Creating Antibody-Coupled RDC Radiopharmaceuticals for Integrated Diagnosis and Therapy
夏亮, 中国医学科学院药物研究所副研究员
XIA Liang, Associate Researcher, Institute of Materia Medica, Chinese Academy of Medical Sciences
14:20 - 14:40
项目2
Project 2
小分子靶向偶联药物的发展前景
Prospects and Potential of Small-Molecule Targeted Conjugate Drugs
王文智, 天津市医药集团有限公司项目经理
WANG Wenzhi, Senior Project Manager of Tianjin Pharmaceutical Group Co., Ltd.
14:40 - 15:00
项目3
Project 3
生物凝聚体/生物相分离赋能多特异性药物的理性设计与开发
Rational Design and Development of Multi-specific Drugs Enabled by Condensates/LLPS
陈冠良, 江苏柯菲平医药股份有限公司医学科学家
CHEN Guanliang, Medical Scientist of Jiangsu Carephar Pharmaceutical Co., Ltd.
15:00 - 15:20
项目4
Project 4
新一代CLDN6 ADC及双荷载ADC
Best-in-class CLDN6 ADC & Dual-payload ADC
姬勋, 齐济投资投资总监
Jason JI, Investment Director of TTM Capital
15:20 - 15:40
项目5
Project 5
基因编辑与细胞治疗下一代创新疗法
Innovative Therapies at the Frontier: Gene Editing and Cell Therapy
李艳萍, 中国医学科学院医药生物技术研究所研究员
LI Yanping, Senior Researcher, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
15:40 - 16:00
项目6
Project 6
全球首创大规模药物设计筛选技术平台-SigmaHit的应用实践
The World's First Large-Scale Drug Design and Discovery Platform - Practical Applications of SigmaHit
张可辉, 中国医学科学院药物研究所副研究员
ZHANG Kehui, Associate Research Fellow, Institute of Materia Medica, Chinese Academy of Medical Sciences
16:00 - 16:20
项目7
Project 7
全球首创新冠广效性新药SNS812-二期临床成功达标数据发表
The World's First Broad-Spectrum COVID-19 Drug SNS812: Phase II Clinical Trial Successfully Achieves Endpoints and Releases Data
谭国超, 华安证券副所长、医药首席分析师
TAN Guochao, Deputy Director & Chief Analyst of Pharmaceutical Industry of Huaan Securities Research Institute
16:20 - 16:40
项目8
Project 8
“璞玉”AI前药技术平台驱动的创新药研发
Innovative Drug Discovery Driven by “Jade” AI Prodrug Platform
杨悦, 中国药促会政策专委会副主委，清华大学药学院研究员、转化与监管科学卓越中心主任
YANG Yue, Vice-Chairman, PhIRDA Medicinal Policy Specialty Committee ；Research Fellow, Tsinghua University School of Pharmaceutical Sciences; Director, Center for Excellence in Translational and Regulatory Science
16:40 - 17:00
项目9
Project 9
先博生物：双引擎驱动下一代通用型细胞治疗的未来
Simnova: Dual Engines Powering the Future of Next-gen Universal Cell Therapies
杨烨辉, 华金证券产业投行部总经理
YANG Yehui, General Manager of Industry Investment Banking Department, HuaJin Securities
17:00 - 17:20
项目10
Project 10
TRD209：用于恶性肿瘤的SHP2降解剂
TRD209: A SHP2 Degrader for Malignant Tumors
高一潇, 北京清准医学科技有限公司首席科学官
GAO Yixiao, Chief Scientific Office of TP MedTech Co., Ltd.
会议咨询